Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)

European Journal of Clinical Pharmacology

Volumn 54, Issue 8, 1998, Pages 589-594

  Ernst, E ^a   Rand, J I ^a   Barnes, J ^a   Stevinson, C ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Adverse drug reaction; Depression; Hypericum perforatum

Indexed keywords

HYPERICUM PERFORATUM EXTRACT;

CONFUSION; DATA BASE; DEPRESSION; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; FATIGUE; HUMAN; HYPERICUM PERFORATUM; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SEDATION; VERTIGO; WORLD HEALTH ORGANIZATION;

ANTIDEPRESSIVE AGENTS; DRUG MONITORING; HUMANS; PHOTOSENSITIZING AGENTS; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS; THEALES;

EID: 0031741887     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050519     Document Type: Review

References (40)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity study. Arch Gen Psychiatry 51: 8-19
2. Waern M, Beskow J, Runeson B, Skoog I (1996) High rate of antidepressant treatment in elderly people who commit suicide. BMJ 313: 1118
3. Burrows G, Norman T (1997) Antidepressants: clinical aspects. Stress Med 13: 167-172
4. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996) St John's wort for depression an overview and meta-analysis of randomised clinical trials. BMJ 313: 253-258
5. Hakima P (1991) Wirksamkeit des Johanniskrautextraktes LI 160 bei depressiver Verstimmung. Nervenheilkunde 10: 250-253
6. Hänsgen KD, Vesper J, Ploch M (1994) Multi-center double-blind study examining the antidepressant effectiveness of the Hypericum extract LI 160. J C Geriatr Psychiatry Neurol 7(Suppl 1): 15-18
7. Harrer G, Schmidt U, Kuhn U (1991) "Alternative" Depressionsbehandlung mit einem Hypericum-Extrakt. Therapiewoche Neurol Psychiatr 5: 710-716
8. Hoffmann J, Kühl ED (1979) Therapie von depressiven Zuständen mit Hypericin. Z Allgemeinmed 55: 776-782
9. Hübner WD, Lande S, Podzuweit H (1994) Hypericum treatment of mild depression with somatic symptoms. J Geriatr Psychiatry Neurol 7(suppl 1): 12-15
10. Lehrl S, Woelk H (1993) Ergebnisse von Messungen der kognitiven Leistungsfähigkeit bei Patienten unter der Therapie mit Johanniskraut. Nervenlieilkunde 12: 281-284
11. Osterheider M, Schmidtke A, Beckmann H (1992) Behandlung depressiver Syndrome mit Hypericum (Johanniskraut) eine placebokontrollierte Doppelblindstudie. Forischr Neurol/Psychiatr 60(Suppl 2): 210-211
12. Quandt J, Schmidt U, Schenk N (1993) Ambulante Behandlung leichter und mittelschwerer depressiver Verstimmungen. Allgemeinarzt 2: 97-102
13. Reh C, Laux P, Schenk N (1992) Hypericum-Extrakte bei Depressionen eine wirksame Alternative. Therapiewoche 42: 1576-1581
14. Schlich D, Braukmann F, Schenk N (1987) Behandlung depressiver Zustände mit Hypericin. Psycho 13: 440-447
15. Schmidt U, Schenk N, Schwarz I, Vorberg G (1989) Zur Therapie depressiver Verstimmungen. Psycho 15: 665-671
16. Schmidt U, Sommer H (1993) Johanniskraut-Extrakt zur ambulanten Therapie der Depression. Fortschr Med 111: 339-342
17. Sommer H, Harrer G (1994) Placebo-controlled double-blind study examining the effectiveness of an Hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol 7(Suppl 1): 9-11
18. Witte B, Harrer G, Kaplan T, Podzuweit H, Schmidt U (1995) Treatment of depressive symptoms with a high concentration hypericum preparation. A multicenter, placebo-controlled, double-blind study. Fortschr Med 113: 404-408
19. Ernst F (1995) St. John's wort, an anti-depressant? A systematic, criteria-based review. Phytomed 2: 67-71
20. Bergmann R, Nübner J, Demling J (1993) Behandlung leichter his mittelschwerer Depressionen. TW Neurol Psychiatr 7: 235-240
21. Harrer G, Hübner WD, Podzuweit H (1994) Effectiveness and tolerance of the Hypericum extract LI 160 compared to maprotiline: a multi-center double-blind study. J Geriatr Neurol Psychiatry 7(Suppl 1): 24-28
22. Kugler J, Weidenhammer W, Schmidt A, Groll S (1990) Therapie depressiver Zustände. Z Allgemeinmed 66: 21-29
23. Vorbach HU, Hübner WD, Arnoldt KH (1994) Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine: randomized double-blind study in 135 outpatients. J Geriatr Psychiatry Neurol 7(Suppl 1): 19-23
24. Vorbach EU, Arnoldt KH, Hübner WD (1997) Efficacity and tolerability of St. John's wort extract LI 160 versus impramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatr 30 (Suppl 2): 81-85
25. Werth W (1989) Psychotonin M versus Imipramin in der Chirurgie. Der Kassenarzt 15: 64-68
26. Wheatley D (1997) LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients a controlled 6-week trial. Pharmacopsychiatr 30(Suppl 2): 77-80
27. Woelk H, Burkard G, Grünwald J (1994) Benefits and risks of the Hyperieum extract LI 160. Drug monitoring study with 3250 patients. J Geriatr Psychiatry Netirol 7(Suppl 1): 34-38
28. Albrecht M, Hubner WD, Podzuweit H, Schmidt U (1994) St. John's wort extract in the treatment of depression: observations on the use of Jarsin capsules. Der Kassenarzt 41: 45-54
29. Grube B, Schermuck S, Hopfenmuller W, Michel F (1997) Use of a hypericum extract in mild, transient depressive disorders. Eur J Clin Res 9: 293-302
30. Meier B, Liske E, Rosinus V (1997) Wirksamkeit und Verträglichkeit eines standardisierten Johanniskraut-Vollextrakts (2e117) bei Patienten mit depressiver Symptomatik unterschiedlicher Schweregrade eine Anwendebeobachtung. Forsch Komplementärmed 4: 87-93
31. Bombardelli E, Morazzoni P (1995) Hypericum perforatum. Fitoterapia 66: 43-68
32. Newall CA, Anderson LA, Phillipson JD (1996) Herbal medicines. The Pharmaceutical Press, London
33. Golsch S, Vocks F, Rakoski J, Brockow K, Ring J (1997) Reversible Erhöhung der Photosensitivität im UV-B-Bereich durch Johanniskrautextrakt-Präparate. Hautarzt 48: 249-252
34. Brockmöller J, Reum T, Bauer S, Kerb R, Hübner W, Roots I (1997) Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30(Suppl 2): 94-101
35. Schulz V, Hansel R, Tyler V (1998) Rational phytotherapy a physician's guide to herbal medicine. Springer-Verlag, Berlin Heidelberg New York
36. Schmidt U, Harrer G, Kuhn U, Berger-Deinert W, Luther D (1993) Wechselwirkungen von Hypericum-Extrakt mit Alkohol. Nervenheilkunde 6: 314-319
37. Thiede H, Walper A (1994) Inhibition of MAO and COMT by hypericum extracts and hypericin. J Geriatr Psychiatry Neurol 7(Suppl 1): 54-56
38. Bladt S, Wagner H (1994) Inhibition of MAO by fractions and constituents of hypericum extract. J Geriatr Psychiatry Neurol 7(Suppl 1): 57-59
39. Ernst E (1992) Placebo forte. Wien Med Wochenschr 142: 217-219
40. De Smet PAGM (1996) St. John's wort as an antidepressant. BMJ 313: 241-242